Literature DB >> 32203076

The prevalence and predictors of pre-hypertension and hypertension in Kherameh cohort study: a population based study on 10,663 persons in south of Iran.

Abbas Rezaianzadeh1, Fatemeh Jafari2, Seyed Ebrahim Sadeghi3, Salar Rahimikazerooni1.   

Abstract

Hypertension (HTN) is an important risk factor for cardiovascular disease (CVD) mortality and morbidity among Iranians. The present study aimed to estimate the prevalence of pre-HTN and HTN and some of its related factors in south of Iran. This cross-sectional survey was conducted on the data of the Persian cohort study in Kherameh. The participants consisted of 10,663 people aged 40-70 years. HTN was defined as either systolic/diastolic blood pressure (SBP/DBP) ≥140/90 mmHg or taking medications. Pre-HTN was defined as SBP = 120-139 mmHg and/or DBP = 80-89 mmHg. The logistic regression method was used to identify the factors associated with pre-HTN and HTN. The age-standardized prevalence rate (ASPR) of pre-HTN was 19.66% (95% CI: 19.45-19.86%) and 18.59% (95% CI: 18.36-18.83%) in males and females, respectively. Also, the ASPR of HTN was 21.44 (95% CI: 21.22-21.65%) in males and 33.53% (95% CI: 33.22-33.85%) in females. Male gender, old age, being unemployed, low education level, high body mass index (BMI), no smoking, diabetes, cerebro-cardiovascular disease, suffering from another chronic disease, family history of CVD, and negative family history of cancer and other chronic diseases were independently associated with pre-HTN (p < 0.05). All variables, except for gender, smoking, and family history of cancer, were significantly associated with HTN. Drug abuse was also correlated to HTN (p < 0.05). This study revealed the increased prevalence of HTN in rural and urban areas. Therefore, the health system needs to develop strategies to raise the accessibility of screening and diagnostic services.

Entities:  

Year:  2020        PMID: 32203076     DOI: 10.1038/s41371-020-0330-8

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  32 in total

1.  Social disparities in prevalence, treatment and control of hypertension in Iran: second National Surveillance of Risk Factors of Noncommunicable Diseases, 2006.

Authors:  Mitra Ebrahimi; Mohammad A Mansournia; Ali A Haghdoost; Arash Abazari; Farshid Alaeddini; Ali Mirzazadeh; Masud Yunesian
Journal:  J Hypertens       Date:  2010-08       Impact factor: 4.844

Review 2.  Reducing the burden of chronic diseases: a neglected agenda in Iranian health care system, requiring a plan for action.

Authors:  Sadaf Ghajarieh Sepanlou; Farin Kamangar; Hossein Poustchi; Reza Malekzadeh
Journal:  Arch Iran Med       Date:  2010-07       Impact factor: 1.354

Review 3.  Hypertension in the developing world: challenges and opportunities.

Authors:  Bharati V Mittal; Ajay K Singh
Journal:  Am J Kidney Dis       Date:  2009-12-05       Impact factor: 8.860

4.  The prevalence of pre-hypertension and hypertension in an Iranian urban population.

Authors:  Ahmad Khosravi; Mohammad Hassan Emamian; Mohammad Shariati; Hassan Hashemi; Akbar Fotouhi
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-11-23

5.  National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; John K Lin; Gitanjali M Singh; Christopher J Paciorek; Melanie J Cowan; Farshad Farzadfar; Gretchen A Stevens; Stephen S Lim; Leanne M Riley; Majid Ezzati
Journal:  Lancet       Date:  2011-02-03       Impact factor: 79.321

6.  The prevalence, awareness and control rate of hypertension among elderly in northwest of Iran.

Authors:  Samad Ghaffari; Leili Pourafkari; Arezou Tajlil; Mohammad Hassan Sahebihagh; Asghar Mohammadpoorasl; Jafar Sadegh Tabrizi; Nader D Nader; Akbar Azizi Zeinalhajlou
Journal:  J Cardiovasc Thorac Res       Date:  2016-12-30

7.  Differences in prevalence of hypertension and associated risk factors in urban and rural residents of the northeastern region of the People's Republic of China: A cross-sectional study.

Authors:  Junnan Wang; Wei Sun; George A Wells; Zhibo Li; Tianyi Li; Junduo Wu; Yangyu Zhang; Yingyu Liu; Longbo Li; Yunpeng Yu; Yihang Liu; Chao Qi; Yang Lu; Ning Liu; Youyou Yan; Lulu Liu; Gang Hui; Bin Liu
Journal:  PLoS One       Date:  2018-04-05       Impact factor: 3.240

8.  Prevalence and associated factors of hypertension among adult patients in Felege-Hiwot Comprehensive Referral Hospitals, northwest, Ethiopia: a cross-sectional study.

Authors:  Amare Belachew; Tilahun Tewabe; Yihun Miskir; Ermias Melese; Endalew Wubet; Saba Alemu; Tewabech Teshome; Yezibalem Minichel; Getasew Tesfa
Journal:  BMC Res Notes       Date:  2018-12-10

9.  Prevalence, awareness, treatment, control, and risk factors of hypertension among adults: a cross-sectional study in Iran.

Authors:  Maryam Eghbali; Alireza Khosravi; Awat Feizi; Asieh Mansouri; Behzad Mahaki; Nizal Sarrafzadegan
Journal:  Epidemiol Health       Date:  2018-05-18

10.  Prevalence of hypertension and prehypertension and its associated cardioembolic risk factors; a population based cross-sectional study in Alkharj, Saudi Arabia.

Authors:  Abdurrahman Aldiab; Mamdouh M Shubair; Jamaan M Al-Zahrani; Khaled K Aldossari; Sameer Al-Ghamdi; Mowafa Househ; Hira Abdul Razzak; Ashraf El-Metwally; Hoda Jradi
Journal:  BMC Public Health       Date:  2018-11-29       Impact factor: 3.295

View more
  2 in total

1.  The prevalence and predictors of cardiovascular diseases in Kherameh cohort study: a population-based study on 10,663 people in southern Iran.

Authors:  Najibullah Baeradeh; Masoumeh Ghoddusi Johari; Leila Moftakhar; Ramin Rezaeianzadeh; Seyed Vahid Hosseini; Abbas Rezaianzadeh
Journal:  BMC Cardiovasc Disord       Date:  2022-05-28       Impact factor: 2.174

2.  The Prevalence of Hypertension in the Population without Awareness of the Disease: Data from a Rural Town of Shandong Province, China.

Authors:  Maoti Wei; Li Dong; Fenghua Wang; Kai Cui; Jiamin Yu; Delong Ma; Ning Yang; Yuming Li
Journal:  Int J Hypertens       Date:  2021-11-03       Impact factor: 2.420

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.